SciELO - Scientific Electronic Library Online

 
vol.12 número47Vacuna conjugada contra el neumococo: ¿Es una prevención universal adecuada de la enfermedad neumocócica?¿Se puede predecir clínicamente qué niños pueden presentar complicaciones intracraneales después de sufrir un traumatismo craneal leve? índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Pediatría Atención Primaria

versão impressa ISSN 1139-7632

Resumo

GARCIA VERA, C.. The state of pneumococci asymptomatic carrier in children and its relation to the invasive disease: What has changed after the conjugated vaccine introduction?. Rev Pediatr Aten Primaria [online]. 2010, vol.12, n.47, pp.457-482. ISSN 1139-7632.

Some important changes relating to the pneumococcal invasive disease (PID) have happened in the last decade in developed countries. The effectiveness of the pneumococcal conjugate heptavalent vaccine (PCV-7) in diminishing the PID by the serotypes included (STV) has been proved after its generalization, but some new serotypes not included have aroused with force as cause of PID. Fortunately, the load of the disease by not included serotypes in children younger than five years is much lower than the caused by STV before the vaccine, and this tendency seems steady with time. But this process has followed parallel to similar changes in the nasopharyngeal colonization by pneumococci, very frequent in under five children, so that now STV have dramatically diminished in healthy carriers and have been substituted by non vaccine serotypes that end by causing PID. This serotypes' replacement have made the antibiotic resistances to diminish due to the fact that they were more prevalent among STV. Two new conjugated vaccines have been commercialized recently and they extend the protection to new serotypes. This paper reviews the changes, expectations and uncertainties that open this new stage in conjugated penumococcal vaccines.

Palavras-chave : Streptococcus pneumoniae; Colonization; Nasopharynx; Invasive pneumococcal disease; Pneumococcal conjugated vaccine.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons